4 noviembre 2014
Patients with atrial fibrillation who take the blood thinner dabigatran are at greater risk for major bleeding and gastrointestinal bleeding than those who take warfarin, according to a new study. The findings, based on Medicare claims data, indicate greater caution is needed when prescribing dabigatran to certain high-risk patients.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/q022RmFxnrg/141103192040.htm
